RITUXIMAB‐CONTAINING COMBINED MODALITY THERAPY IN LIMITED STAGE FOLLICULAR LYMPHOMA: MATURE FOLLOW UP AND DERIVATION OF A NOVEL PROGNOSTIC SCORE FROM THE TROG99.03 TRIAL

J. w. Tobin; V. Jurinovic; H. Tsang; D. Roos; R. Tsang; A. Macann; S. Davis; D. Christie; S. Law; K. Nath; M. Sabdia; A. m. Patch; J. Gunawardana; L. Merida de long; E. Hoster; H. Horn; M. Shanavas; L. Li; C. Cheah; A. Benhur; M. Hou; P. O'brien; A. m. Johnston; T. Cochrane; J. Butler; E. Thompson; P. Blombery; J. f. Seymour; M. k. Gandhi; M. Macmanus

doi:10.1002/hon.3163_140

RITUXIMAB‐CONTAINING COMBINED MODALITY THERAPY IN LIMITED STAGE FOLLICULAR LYMPHOMA: MATURE FOLLOW UP AND DERIVATION OF A NOVEL PROGNOSTIC SCORE FROM THE TROG99.03 TRIAL

J. w. Tobin, V. Jurinovic, H. Tsang, D. Roos, R. Tsang, A. Macann, S. Davis, D. Christie, S. Law, K. Nath, M. Sabdia, A. m. Patch, J. Gunawardana, L. Merida de long, E. Hoster, H. Horn, M. Shanavas, L. Li, C. Cheah, A. BenhurM. Hou, P. O'brien, A. m. Johnston, T. Cochrane, J. Butler, E. Thompson, P. Blombery, J. f. Seymour, M. k. Gandhi, M. Macmanus

Research output: Contribution to journal › Abstract/Meeting Abstract

Original language	English
Pages (from-to)	216-217
Journal	Hematological Oncology
Volume	41
Issue number	S2
DOIs	https://doi.org/10.1002/hon.3163_140
Publication status	Published - Jun 2023
Event	17th International Conference on Malignant Lymphoma - Lugano, Switzerland Duration: 13 Jun 2023 → 17 Jun 2023

Access to Document

10.1002/hon.3163_140

Cite this

Tobin, J. W., Jurinovic, V., Tsang, H., Roos, D., Tsang, R., Macann, A., Davis, S., Christie, D., Law, S., Nath, K., Sabdia, M., Patch, A. M., Gunawardana, J., Merida de long, L., Hoster, E., Horn, H., Shanavas, M., Li, L., Cheah, C., ... Macmanus, M. (2023). RITUXIMAB‐CONTAINING COMBINED MODALITY THERAPY IN LIMITED STAGE FOLLICULAR LYMPHOMA: MATURE FOLLOW UP AND DERIVATION OF A NOVEL PROGNOSTIC SCORE FROM THE TROG99.03 TRIAL. Hematological Oncology, 41(S2), 216-217. https://doi.org/10.1002/hon.3163_140

@article{56d1fc2d9fce4ba4aabe43a08513b5b5,

title = "RITUXIMAB‐CONTAINING COMBINED MODALITY THERAPY IN LIMITED STAGE FOLLICULAR LYMPHOMA: MATURE FOLLOW UP AND DERIVATION OF A NOVEL PROGNOSTIC SCORE FROM THE TROG99.03 TRIAL",

keywords = "diagnostic and prognostic biomarkers, indolent non-Hodgkin lymphoma, radiation therapy",

author = "Tobin, {J. w.} and V. Jurinovic and H. Tsang and D. Roos and R. Tsang and A. Macann and S. Davis and D. Christie and S. Law and K. Nath and M. Sabdia and Patch, {A. m.} and J. Gunawardana and {Merida de long}, L. and E. Hoster and H. Horn and M. Shanavas and L. Li and C. Cheah and A. Benhur and M. Hou and P. O'brien and Johnston, {A. m.} and T. Cochrane and J. Butler and E. Thompson and P. Blombery and Seymour, {J. f.} and Gandhi, {M. k.} and M. Macmanus",

year = "2023",

month = jun,

doi = "10.1002/hon.3163_140",

language = "English",

volume = "41",

pages = "216--217",

journal = "Hematological Oncology",

issn = "0278-0232",

publisher = "John Wiley & Sons",

number = "S2",

note = "17th International Conference on Malignant Lymphoma ; Conference date: 13-06-2023 Through 17-06-2023",

}

Tobin, JW, Jurinovic, V, Tsang, H, Roos, D, Tsang, R, Macann, A, Davis, S, Christie, D, Law, S, Nath, K, Sabdia, M, Patch, AM, Gunawardana, J, Merida de long, L, Hoster, E, Horn, H, Shanavas, M, Li, L, Cheah, C, Benhur, A, Hou, M, O'brien, P, Johnston, AM, Cochrane, T, Butler, J, Thompson, E, Blombery, P, Seymour, JF, Gandhi, MK & Macmanus, M 2023, 'RITUXIMAB‐CONTAINING COMBINED MODALITY THERAPY IN LIMITED STAGE FOLLICULAR LYMPHOMA: MATURE FOLLOW UP AND DERIVATION OF A NOVEL PROGNOSTIC SCORE FROM THE TROG99.03 TRIAL', Hematological Oncology, vol. 41, no. S2, pp. 216-217. https://doi.org/10.1002/hon.3163_140

TY - JOUR

T1 - RITUXIMAB‐CONTAINING COMBINED MODALITY THERAPY IN LIMITED STAGE FOLLICULAR LYMPHOMA: MATURE FOLLOW UP AND DERIVATION OF A NOVEL PROGNOSTIC SCORE FROM THE TROG99.03 TRIAL

AU - Tobin, J. w.

AU - Jurinovic, V.

AU - Tsang, H.

AU - Roos, D.

AU - Tsang, R.

AU - Macann, A.

AU - Davis, S.

AU - Christie, D.

AU - Law, S.

AU - Nath, K.

AU - Sabdia, M.

AU - Patch, A. m.

AU - Gunawardana, J.

AU - Merida de long, L.

AU - Hoster, E.

AU - Horn, H.

AU - Shanavas, M.

AU - Li, L.

AU - Cheah, C.

AU - Benhur, A.

AU - Hou, M.

AU - O'brien, P.

AU - Johnston, A. m.

AU - Cochrane, T.

AU - Butler, J.

AU - Thompson, E.

AU - Blombery, P.

AU - Seymour, J. f.

AU - Gandhi, M. k.

AU - Macmanus, M.

PY - 2023/6

Y1 - 2023/6

KW - diagnostic and prognostic biomarkers

KW - indolent non-Hodgkin lymphoma

KW - radiation therapy

UR - https://onlinelibrary.wiley.com/doi/10.1002/hon.3163_140

U2 - 10.1002/hon.3163_140

DO - 10.1002/hon.3163_140

M3 - Abstract/Meeting Abstract

SN - 0278-0232

VL - 41

SP - 216

EP - 217

JO - Hematological Oncology

JF - Hematological Oncology

IS - S2

T2 - 17th International Conference on Malignant Lymphoma

Y2 - 13 June 2023 through 17 June 2023

ER -

RITUXIMAB‐CONTAINING COMBINED MODALITY THERAPY IN LIMITED STAGE FOLLICULAR LYMPHOMA: MATURE FOLLOW UP AND DERIVATION OF A NOVEL PROGNOSTIC SCORE FROM THE TROG99.03 TRIAL

Access to Document

Other files and links

Cite this